Article Details

Zeiss Medical Technology gains NMPA approval for ILM-Blue in China

Retrieved on: 2025-04-01 16:07:40

Tags for this article:

Click the tags to see associated articles and topics

Zeiss Medical Technology gains NMPA approval for ILM-Blue in China. View article details on hiswai:

Summary

The article discusses Zeiss Medical Technology's launch of ILM-Blue in China, following its acquisition of DORC. This highlights Zeiss’s commitment to expanding high-quality ophthalmology solutions, reflecting the tags' focus on the company's involvement in this field.

Article found on: www.ophthalmologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up